InsiderTrades

Form 4 for AXTI AXT INC

Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-04 · accession 0001437749-25-037125 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2025-12-08 2025-12-04 AXTI YOUNG MORRIS S CEO S - Sale+OE $12.05 -35.0K 2.50M -1% -$421.8K
DM 2025-12-08 2025-12-04 AXTI YOUNG MORRIS S CEO M - OptEx $4.33 +69.2K 2.49M +3% +$300.0K
DM 2025-12-08 2025-12-04 AXTI YOUNG MORRIS S CEO M - OptEx $0.00 -69.2K 552.7K -11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-04 S D 35,000 $12.05 2,495,564 I — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.92 to $12.13,inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate transaction.
2 Common Common Stock 2025-12-04 M A 19,193 $5.21 2,530,564 D — — (F3) Exercise of restricted stock awards which were originally granted on 10/28/2016 and became first exercisable on 10/28/2017.
3 Common Common Stock 2025-12-04 M A 17,331 $5.77 2,511,371 D — — (F2) Exercise of restricted stock awards which were originally granted on 11/05/2018 and became first exercisable on 11/05/2019.
4 Common Common Stock 2025-12-04 M A 32,680 $3.06 2,494,040 D By Young Family Trust DTD — — (F1) Exercise of restricted stock awards which were originally granted on 11/06/2019 and became first exercisable on 11/06/2020.
5 Derivative Stock Option (Right to Buy) 2025-12-04 M D 32,680 $0.00 589,273 D $3.06 · 2020-11-06 to 2029-11-06 32,680 Common Stock (F5) Exercise of restricted stock awards which were originally granted on 11/06/2019 and became first exercisable on 11/06/2020.
6 Derivative Stock Option (Right to Buy) 2025-12-04 M D 17,331 $0.00 571,942 D $5.77 · 2019-11-05 to 2028-11-05 17,331 Common Stock (F6) Exercise of restricted stock awards which were originally granted on 11/05/2018 and became first exercisable on 11/05/2019.
7 Derivative Stock Option (Right to Buy) 2025-12-04 M D 19,193 $0.00 552,749 D $5.21 · 2017-10-28 to 2026-10-28 19,193 Common Stock (F7) Exercise of restricted stock awards which were originally granted on 10/28/2016 and became first exercisable on 10/28/2017.